Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone Chronotherapy in DMD
NCT02036463Phase 2Withdrawn
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Nov 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisone in Duchenne muscular dystrophy (DMD), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Planned start Nov 2014; status: withdrawn.
02
Drugs
prednisone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT02036463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02036463.